TCL Archive Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say July 24, 2009
TCL Archive House Committee Aims To Cut Markup On Office-Administered Cancer Drugs. November 16, 2001
TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999